首页> 外文期刊>World Journal of Gastroenterology >Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey.
【24h】

Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey.

机译:肝硬化患者与门脉高压相关的消化性出血的处理:法国多中心横截面实践调查。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the conformity of management practices of gastrointestinal hemorrhage in cirrhotic patients with relevant guidelines. METHODS: A questionnaire on the management of digestive bleeding was completed for all consecutive cirrhotic patients admitted to 31 French hospitals. RESULTS: One hundred and twenty-six bleeding events were recorded. It was the first bleeding episode in 79 patients (63%), of whom 40 (51%) had a prior diagnosis of cirrhosis and 25 (32%) had previously undergone an endoscopy. The bleeding episode was a recurrence in 46 patients (37%). The median time between onset and admission was 4 h, but exceeded 12 h in 42% of cases. There was an agreement between centers for early vasoactive drug administration (87% of cases), association with ligation (42%) more often than sclerosis (21%) at initial endoscopy, and antibiotic prophylaxis (64%). By contrast, prescription of beta-blockade alone or in combination (0 to 100%, P = 0.003) for secondary prophylaxis and lactulose (26% to86%, P = 0.04), differed among centers. CONCLUSION: In French hospitals, management of bleeding related to portal hypertension in cirrhotic patients is generally in keeping with the consensus. Broad variability still remains concerning beta-blockade use for secondary prophylaxis. Screening for esophageal varices, the use of antibiotic prophylaxis and patients information need to be improved.
机译:目的:探讨肝硬化患者消化道出血的管理实践与相关指南的符合性。方法:完成了对法国31所医院中所有连续性肝硬化患者的消化性出血管理问卷。结果:共记录126次出血事件。这是79例患者(63%)的首次出血事件,其中40例(51%)曾被诊断为肝硬化,25例(32%)曾接受内镜检查。出血发作在46例患者中复发(37%)。发病至入院的中位时间为4小时,但在42%的病例中超过12小时。在早期血管活性药物治疗中心(87%的案例)之间达成了协议,在初次内窥镜检查时,结扎的相关性(42%)比硬化症(21%)更频繁,抗生素的预防(64%)。相比之下,在各个中心,单独或联合使用β受体阻滞剂(0至100%,P = 0.003)和乳果糖的处方(26%至86%,P = 0.04)有所不同。结论:在法国医院,肝硬化患者门脉高压相关的出血处理通常与共识一致。关于β受体阻滞剂在二级预防中的应用,仍存在广泛的差异。食管静脉曲张的筛查,抗生素预防的使用和患者信息有待改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号